SPERO THERAPEUTICS INC
SPRONASDAQ🏆 #3811 by market capEarnings Aug 12US Equity
$1.23▼ $0.01 (−0.41%)
Live1h▲ 0.0%
24h▼ 0.4%
7d▼ 3.5%
14d▲ 2.1%
30d▼ 43.8%
1y▼ 48.0%
🏦Market Cap
$71M
Small Cap
📈Revenue Growth (YoY)
+24.3%
Healthy
📊Gross Margin
100.0%
High
💵FCF Margin
13.2%
Healthy
⚖️P/S Ratio
1.3x
Cheap
Otter Score
45
Weak
📊
Analyst Ratings
Price
$1.23
Total
13
Raised
0
Lowered
7
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2025-01-30 |
Evercore ISI Group | Downgraded | Outperform → In Line | 2024-12-20 |
TD Cowen | Downgraded | Buy → Hold | 2024-11-18 |
Berenberg | Downgraded | Buy → Hold | 2022-05-20 |
Cantor Fitzgerald | Reiterated | Overweight | 2022-05-17 |
Cowen & Co. | Downgraded | Outperform → Market Perform | 2022-05-04 |
Oppenheimer | Downgraded | Outperform → Perform | 2021-10-01 |
Stifel | Reiterated | Buy | 2020-03-17 |
H.C. Wainwright | Reiterated | Buy | 2019-11-05 |
Janney Capital | Reiterated | Buy | 2019-09-09 |
B of A Securities | Downgraded | Neutral → Underperform | 2018-10-16 |
Bank of America | Downgraded | Neutral → Underperform | 2018-10-16 |
Stifel Nicolaus | Reiterated | Buy | 2017-11-27 |
One row per institution, most recent rating